Allergic bronchopulmonary aspergillosis in cystic fibrosis.
The current standards of care for allergic bronchopulmonary aspergillosis in patients with cystic fibrosis are presented. Recent studies have increased understanding of the inflammatory process that occurs in cystic fibrosis patients with allergic bronchopulmonary aspergillosis. This has resulted in more precise diagnostic criteria that facilitate more timely diagnosis and treatment of ABPA in these patients. In addition to traditional treatment with systemic corticosteroids, promising results have been documented with antifungal therapy.
Hanley-Lopez
J
J
Division of Allergy and Immunology, University of Southern California School of Medicine, Los Angeles, 90033, USA. kmjhanley@aol.com
Clement
L T
LT
D000935:Antifungal Agents / Q000627:therapeutic use; D001229:Aspergillosis, Allergic Bronchopulmonary / Q000150:complications / Q000175:diagnosis* / Q000276:immunology / Q000628:therapy*; D003550:Cystic Fibrosis / Q000150:complications*; D006801:Humans; D017964:Itraconazole / Q000627:therapeutic use
D000935:Antifungal Agents; D017964:Itraconazole